PolyTherics Ltd - News on 28 June 2006

2008
PolyTherics to Present Therapeutic Protein Optimisation Platform at BIO-Europe Meeting
PolyTherics and Alligator Bioscience announces strategic collaboration for optimisation of next generation biopharmaceuticals
Secretary of State John Denham visits PolyTherics
Novel Approach to Drug Insolubility strengthens PolyTherics patent estate
PolyTherics expands Collaboration with Biocompatibles
PolyTherics-Celtic Pharma Collaboration Agreement to explore technologies for improved drug performance
New Consortium announces Significant Grant Funding of Anaemia product programme

2007
Innovative Drug Production Project secures funding from Technology Strategy Board
Imperial Innovations Annual Report - PolyTherics Limited
PolyTherics highlighted by UK Trade & Investment
Antony Godwin from PolyTherics ties the knot
PolyTherics and BioVectra dcl sign Manufacturing and Representation Deal
Innovative Biopharmaceutical Company, PolyTherics, raises over £2 million
TheraPEG ™ technology ideal for drugs for developing countries

2006
TheraPEG ™ technology wins Research Breakthrough Award
NHS at Hammersmith Hospital applauds new PEGylated IFN
PolyTherics nominated Regional Finalist in UK Biotechnology Entrepreneur Awards 2006
PolyTherics PEGylation technology published in Nature
Debbie Allen and Geeta Gupta joins PolyTherics

2005
PolyTherics and Shantha sign biotech deal
BangaloreBio begins
British High Commissioner addresses Indian biotech companies

Previous | Next
PolyTherics is nominated as Regional Finalist for the UK Biotechnology Entrepreneur Awards 2006

PolyTherics has been nominated as one of the Regional Finalists for the UK Innovation in Enabling Biotechnology Award 2006 at the first UK Biotechnology Entrepreneur Awards 2006.

The award recognises the role research plays in developing technologies that facilitate drug discovery and development.

The awards are hosted by government organisation UK Trade & Investment and the business organisation London First.

UK Trade & Investment chief executive Andrew Cahn said the event was an opportunity for the country to build on its reputation as a bio-science world leader.

---
28 June 2006

Previous | Next